Status:
COMPLETED
The Study of the Impact of Disclosing Imaging Study Information to Trial Participants
Lead Sponsor:
Institute for Neurodegenerative Disorders
Conditions:
Parkinsonian Syndrome
Parkinson
Eligibility:
All Genders
21+ years
Brief Summary
The overall goal of the study is to evaluate how research participants in Parkinson Disease studies that include brain imaging with a dopamine transporter ligand choose to receive the imaging data and...
Detailed Description
Research participants who previously underwent ß-CIT imaging will be contacted by the staff at IND to enquire whether they would like to receive their ß-CIT scan data. After signing a Research Partici...
Eligibility Criteria
Inclusion
- Previous participation in imaging study as described within the protocol
Exclusion
- \-
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2008
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00354003
Start Date
July 1 2006
End Date
August 1 2008
Last Update
April 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Neurodegenerative Disorders
New Haven, Connecticut, United States, 06510